In terms of regulation 5(4) of the Control of Concentrations Regulations, 2002 published in Legal Notice 294 of 2002, the Director General of the Office for Competition notifies for general information that a notification of a concentration between Prohealth Limited (Zebbug) and TrioMed Holdings Limited (Ta’ Xbiex) was filed on Monday, 2 January 2023.
The nature of the concentration is the acquisition by Prohealth Limited of sole control of TrioMed Limited through holding company TrioMed Holdings Limited.
Prohealth Limited is a supplier of a range of health and well-being products, namely; dermo-cosmetic products, pharmaceutical products, dental hygiene products, infection control products and medical consumables. TrioMed Limited is a supplier of medical equipment, namely; hospital beds, radiology diagnostic equipment, patient monitoring equipment, clinical informatics software, patient monitoring systems, ultrasound machines and patient ventilation.
The Director General of the Office for Competition invites interested third parties to submit their written objections on this notified concentration within seven days following publication of this notice at the following address: